Brief: Eloxx Pharmaceuticals Says Board Approved Leadership And Organizational Re-Alignment

Eloxx Pharmaceuticals

26/02/2020 23:02

Feb 26 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS INC - ON FEB 24, BOARD APPROVED A
LEADERSHIP AND ORGANIZATIONAL RE-ALIGNMENT
    * ELOXX PHARMACEUTICALS - ORGANIZATIONAL RE-ALIGNMENT WILL
RESULT
IN ELIMINATION OF 13 FULL-TIME POSITIONS
    * ELOXX PHARMACEUTICALS - CHANGES AS A RESULT OF
ORGANIZATIONAL
RE-ALIGNMENT WILL TAKE PLACE EFFECTIVE MAR 1
    * ELOXX PHARMACEUTICALS INC - AS A RESULT OF RE-ALIGNMENT,
EXPECTS
TO ACHIEVE ANNUAL COST SAVINGS OF ABOUT $4.9 MILLION
    * ELOXX PHARMACEUTICALS- AS A RESULT OF RE-ALIGNMENT,
EXPECTS TO
INCUR ONE-TIME PRE-TAX CHARGE, CONSISTING OF EMPLOYEE SEPARATION
COSTS OF ABOUT $1.7 MILLION

Source: (https://bit.ly/32xfG3v)
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))